EMIT 2000 Sirolimus Assay

Monitoring sirolimus levels in transplant patients is essential to ensuring the delicate balance between appropriate immunosuppression and transplant rejection. With the EMIT^® 2000 sirolimus method, laboratories have a flexible and convenient solution to help clinicians effectively manage sirolimus therapy in their transplant patients.

��Features��

Simple sample pretreatment
Results in as little as 14 minutes
No reagent preparation required
Correlates to LC/MS/MS

��Advantages

Streamlined ISD monitoring and enhanced productivity
Benefit from up to 4 different ISD methods on one single V-Twin^® or Viva-E^® drug testing system*

Assay Specifications

��	Emit 2000 SIRO Assay
Product Code	8S019UL
Sample Type	EDTA Whole Blood
Pretreatment	Manual
Reportable Range	3.5 -30 ng/mL
Calibration	With new reagent lot
Reagent Stability	Opened at 2-8° C: 4 weeks

Services & Support

Not all assays are available in all countries.

The products/features (mentioned herein) are not commercially available in all countries. Due to regulatory reasons their future availability cannot be guaranteed. Please contact your local Siemens Healthineers organization for further details.

��ӰԺ